• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性遗传性阿尔茨海默病的定量淀粉样蛋白成像:DIAN研究组的结果

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.

作者信息

Su Yi, Blazey Tyler M, Owen Christopher J, Christensen Jon J, Friedrichsen Karl, Joseph-Mathurin Nelly, Wang Qing, Hornbeck Russ C, Ances Beau M, Snyder Abraham Z, Cash Lisa A, Koeppe Robert A, Klunk William E, Galasko Douglas, Brickman Adam M, McDade Eric, Ringman John M, Thompson Paul M, Saykin Andrew J, Ghetti Bernardino, Sperling Reisa A, Johnson Keith A, Salloway Stephen P, Schofield Peter R, Masters Colin L, Villemagne Victor L, Fox Nick C, Förster Stefan, Chen Kewei, Reiman Eric M, Xiong Chengjie, Marcus Daniel S, Weiner Michael W, Morris John C, Bateman Randall J, Benzinger Tammie L S

机构信息

Department of Radiology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.

Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.

出版信息

PLoS One. 2016 Mar 24;11(3):e0152082. doi: 10.1371/journal.pone.0152082. eCollection 2016.

DOI:10.1371/journal.pone.0152082
PMID:27010959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4807073/
Abstract

Amyloid imaging plays an important role in the research and diagnosis of dementing disorders. Substantial variation in quantitative methods to measure brain amyloid burden exists in the field. The aim of this work is to investigate the impact of methodological variations to the quantification of amyloid burden using data from the Dominantly Inherited Alzheimer's Network (DIAN), an autosomal dominant Alzheimer's disease population. Cross-sectional and longitudinal [11C]-Pittsburgh Compound B (PiB) PET imaging data from the DIAN study were analyzed. Four candidate reference regions were investigated for estimation of brain amyloid burden. A regional spread function based technique was also investigated for the correction of partial volume effects. Cerebellar cortex, brain-stem, and white matter regions all had stable tracer retention during the course of disease. Partial volume correction consistently improves sensitivity to group differences and longitudinal changes over time. White matter referencing improved statistical power in the detecting longitudinal changes in relative tracer retention; however, the reason for this improvement is unclear and requires further investigation. Full dynamic acquisition and kinetic modeling improved statistical power although it may add cost and time. Several technical variations to amyloid burden quantification were examined in this study. Partial volume correction emerged as the strategy that most consistently improved statistical power for the detection of both longitudinal changes and across-group differences. For the autosomal dominant Alzheimer's disease population with PiB imaging, utilizing brainstem as a reference region with partial volume correction may be optimal for current interventional trials. Further investigation of technical issues in quantitative amyloid imaging in different study populations using different amyloid imaging tracers is warranted.

摘要

淀粉样蛋白成像在痴呆症的研究和诊断中起着重要作用。该领域在测量脑淀粉样蛋白负荷的定量方法上存在很大差异。这项工作的目的是利用来自显性遗传阿尔茨海默病网络(DIAN)(一种常染色体显性阿尔茨海默病群体)的数据,研究方法差异对淀粉样蛋白负荷定量的影响。对来自DIAN研究的横断面和纵向[11C] - 匹兹堡化合物B(PiB)PET成像数据进行了分析。研究了四个候选参考区域以估计脑淀粉样蛋白负荷。还研究了一种基于区域扩散函数的技术用于校正部分容积效应。在疾病过程中,小脑皮质、脑干和白质区域的示踪剂滞留均稳定。部分容积校正持续提高了对组间差异和随时间纵向变化的敏感性。白质参照提高了检测相对示踪剂滞留纵向变化的统计功效;然而,这种改善的原因尚不清楚,需要进一步研究。全动态采集和动力学建模提高了统计功效,尽管这可能会增加成本和时间。本研究考察了淀粉样蛋白负荷定量的几种技术差异。部分容积校正成为最能持续提高检测纵向变化和组间差异统计功效的策略。对于采用PiB成像的常染色体显性阿尔茨海默病群体,将脑干作为参考区域并进行部分容积校正可能是当前干预试验的最佳选择。有必要进一步研究使用不同淀粉样蛋白成像示踪剂在不同研究群体中进行定量淀粉样蛋白成像的技术问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11f/4807073/616450f8b2d6/pone.0152082.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11f/4807073/616450f8b2d6/pone.0152082.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c11f/4807073/616450f8b2d6/pone.0152082.g001.jpg

相似文献

1
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.常染色体显性遗传性阿尔茨海默病的定量淀粉样蛋白成像:DIAN研究组的结果
PLoS One. 2016 Mar 24;11(3):e0152082. doi: 10.1371/journal.pone.0152082. eCollection 2016.
2
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study.常染色体显性阿尔茨海默病淀粉样β负担的变异依赖性异质性:一项观察性研究的横断面和纵向分析。
Lancet Neurol. 2022 Feb;21(2):140-152. doi: 10.1016/S1474-4422(21)00375-6.
3
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.常染色体显性遗传性阿尔茨海默病中星形细胞增生和淀粉样蛋白PET的纵向变化差异
Brain. 2016 Mar;139(Pt 3):922-36. doi: 10.1093/brain/awv404. Epub 2016 Jan 26.
4
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
5
Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.作为相对脑血流量指标的相对11C-匹兹堡化合物B输送量:使用单时段15O-水和11C-匹兹堡化合物B正电子发射断层显像的定量评估
J Nucl Med. 2015 Aug;56(8):1199-205. doi: 10.2967/jnumed.114.152405. Epub 2015 Jun 4.
6
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.使用正电子发射断层扫描(PET)成像和匹兹堡化合物-B对人体淀粉样蛋白结合进行动力学建模。
J Cereb Blood Flow Metab. 2005 Nov;25(11):1528-47. doi: 10.1038/sj.jcbfm.9600146.
7
Partial volume correction in quantitative amyloid imaging.定量淀粉样蛋白成像中的部分容积校正
Neuroimage. 2015 Feb 15;107:55-64. doi: 10.1016/j.neuroimage.2014.11.058. Epub 2014 Dec 5.
8
Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.阿尔茨海默病的淀粉样蛋白 PET 成像:三种放射性示踪剂的比较。
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407. doi: 10.1007/s00259-014-2753-3. Epub 2014 Mar 20.
9
Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.部分容积效应校正对 APP-Swe 小鼠 [(18)F]-florbetaben PET 脑β-淀粉样蛋白成像的影响。
Neuroimage. 2014 Jan 1;84:843-53. doi: 10.1016/j.neuroimage.2013.09.017. Epub 2013 Sep 20.
10
Optimizing regions-of-interest composites for capturing treatment effects on brain amyloid in clinical trials.在临床试验中优化感兴趣区域复合体以捕捉对脑淀粉样蛋白的治疗效果。
J Alzheimers Dis. 2015;43(3):809-21. doi: 10.3233/JAD-131979.

引用本文的文献

1
Accounting for white matter uptake improves between tracer agreement in amyloid PET.考虑白质摄取可改善淀粉样蛋白PET中示踪剂之间的一致性。
Alzheimers Dement (Amst). 2025 Aug 25;17(3):e70165. doi: 10.1002/dad2.70165. eCollection 2025 Jul-Sep.
2
Differential Impacts of Road Diets on Driving Behavior among Older Adults with and without Preclinical Alzheimer's Pathology.道路缩减措施对有和没有临床前阿尔茨海默病病理特征的老年人驾驶行为的不同影响。
Transp Res Part F Traffic Psychol Behav. 2023 Oct;98:18-28. doi: 10.1016/j.trf.2023.08.010. Epub 2023 Aug 26.
3
Enhancing Amyloid PET Quantification: MRI-Guided Super-Resolution Using Latent Diffusion Models.

本文引用的文献

1
Deformation field correction for spatial normalization of PET images.用于PET图像空间归一化的形变场校正
Neuroimage. 2015 Oct 1;119:152-63. doi: 10.1016/j.neuroimage.2015.06.063. Epub 2015 Jun 30.
2
Quantitative amyloid imaging using image-derived arterial input function.使用图像衍生动脉输入函数的定量淀粉样蛋白成像。
PLoS One. 2015 Apr 7;10(4):e0122920. doi: 10.1371/journal.pone.0122920. eCollection 2015.
3
Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.使用18F-氟代贝他吡PET和标准化摄取值比率测量纵向β-淀粉样蛋白变化。
增强淀粉样蛋白PET定量:使用潜在扩散模型的MRI引导超分辨率
Life (Basel). 2024 Dec 1;14(12):1580. doi: 10.3390/life14121580.
4
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN.糖尿病预防试验(DIAN)中15年的纵向基因、临床、认知、影像学和生化测量
medRxiv. 2024 Aug 9:2024.08.08.24311689. doi: 10.1101/2024.08.08.24311689.
5
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).γ-分泌酶活性、临床特征和常染色体显性阿尔茨海默病的生物标志物:显性遗传性阿尔茨海默病网络观察研究(DIAN-OBS)的横断面和纵向分析。
Lancet Neurol. 2024 Sep;23(9):913-924. doi: 10.1016/S1474-4422(24)00236-9. Epub 2024 Jul 26.
6
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.常染色体显性遗传与散发性早发型阿尔茨海默病的分子神经影像学
Brain Commun. 2024 May 3;6(3):fcae159. doi: 10.1093/braincomms/fcae159. eCollection 2024.
7
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
8
Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease.临床前阿尔茨海默病患者跌倒的诱发机制
J Alzheimers Dis Rep. 2023 Jul 14;7(1):739-750. doi: 10.3233/ADR-230002. eCollection 2023.
9
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN).显性遗传性阿尔茨海默病网络(DIAN)中的正电子发射断层扫描和磁共振成像方法及数据集。
Nat Neurosci. 2023 Aug;26(8):1449-1460. doi: 10.1038/s41593-023-01359-8. Epub 2023 Jul 10.
10
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.PSEN1 致病变异的位置会影响常染色体显性阿尔茨海默病认知、临床和神经退行性变测量指标的进展。
Aging Cell. 2023 Aug;22(8):e13871. doi: 10.1111/acel.13871. Epub 2023 Jun 8.
J Nucl Med. 2015 Apr;56(4):567-74. doi: 10.2967/jnumed.114.148981. Epub 2015 Mar 5.
4
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.通过脑白质参考区域增强纵向淀粉样蛋白β正电子发射断层扫描(PET)变化特征描述及评估淀粉样蛋白修饰治疗的效能。
J Nucl Med. 2015 Apr;56(4):560-6. doi: 10.2967/jnumed.114.149732. Epub 2015 Mar 5.
5
Partial volume correction in quantitative amyloid imaging.定量淀粉样蛋白成像中的部分容积校正
Neuroimage. 2015 Feb 15;107:55-64. doi: 10.1016/j.neuroimage.2014.11.058. Epub 2014 Dec 5.
6
Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.采用基于白质参照和基于感兴趣区的部分容积效应校正的方法改善纵向 [(18)F]-AV45 淀粉样 PET 成像。
Neuroimage. 2015 Mar;108:450-9. doi: 10.1016/j.neuroimage.2014.11.055. Epub 2014 Dec 4.
7
2014 Alzheimer's disease facts and figures.2014 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2014 Mar;10(2):e47-92. doi: 10.1016/j.jalz.2014.02.001.
8
The A4 study: stopping AD before symptoms begin?A4研究:在症状出现前阻止阿尔茨海默病?
Sci Transl Med. 2014 Mar 19;6(228):228fs13. doi: 10.1126/scitranslmed.3007941.
9
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014.从 1984 年到 2014 年对阿尔茨海默病的临床试验和后期药物开发的评价。
J Intern Med. 2014 Mar;275(3):251-83. doi: 10.1111/joim.12191.
10
Quantitative analysis of PiB-PET with FreeSurfer ROIs.使用 FreeSurfer 感兴趣区进行 PiB-PET 的定量分析。
PLoS One. 2013 Nov 6;8(11):e73377. doi: 10.1371/journal.pone.0073377. eCollection 2013.